Contact Us | Data Center Logon | Site Tools | Search   GO
  • Home
  • About Us
    • Welcome
    • History
    • Mission Statement
    • Headquarters Information
      • RTOG Headquarters Hours
    • Site Participation Materials
    • RTOG Password Application
    • Contact Us
    • NRG Oncology Information
  • Patients
    • Welcome
    • Links
      • Clinical Trial Resources
      • Patient Advocacy Groups
      • NIH
    • RTOG Informational Brochure
  • Clinical Trials
    • Welcome
    • Protocol Table
    • RTOG Foundation Studies
    • Non-Study Specific Forms
    • Active Study Accrual List
    • Broadcasts
    • Data Monitoring Committee (DMC)
  • Publications
    • Publications Update
  • Core Lab
    • Active Downloads
    • Advanced Technology Radiation Therapy
    • Contouring Atlases
      • Anorectal
      • Bladder Atlas
      • Brachial Plexus Contouring Atlas
      • Breast Cancer Atlas
      • Female RTOG Normal Pelvis Atlas
      • GYN
      • H & N Atlases
      • Hippocampal Sparing
      • Male RTOG Normal Pelvis Atlas
      • Pancreas Atlas
      • Prostate Pelvic Lymph Nodes
      • Prostate Post-Op
      • RTOG Extremity Soft Tissue Sarcoma Atlas
      • Lung Atlas
      • Upper Abdominal Normal Organ Contouring Consensus
      • RADCOMP Breast Atlas
      • Vulvar Cancer Atlas
    • Standardized Naming Conventions
    • RTQA Protocol Prescription Guidelines
    • Approval Process
    • Education/Training
    • Advanced Imaging
      • MRI/CT Core Lab Information
      • PET Core Lab Information
    • Contact RTQA
    • TRIAD
  • Researchers
    • Welcome
    • Policies & Manuals
      • Procedures Manual
      • Conflict of Interest Policy
      • Scientific Misconduct Policy
      • Data Sharing
      • Publication Guidelines
    • Broadcasts
  • Research Associates
    • Welcome
    • Education/Training
      • VisionTree Training
      • RA Education Materials
    • Adverse Event Reporting
    • Regulatory Information
      • CTSU Filing Requirements
      • Investigator Brochure Archive
      • Guidance Documents
      • Early IRB Closure
      • External Safety Reports
        • ABT-888
        • AMG 386
        • Bevacizumab
        • Cediranib
        • Crizotinib
        • Erlotinib
        • Everolimus
        • Ipilimumab
        • Lapatinib
        • Nivolumab
        • Panitumumab
        • Pazopanib
        • Sorafenib
        • TAK-700
        • Trastuzumab
    • Procedures
      • Lost to Follow-up
      • Patient Transfers
  • News
    • NRG Oncology Newsletters
    • RTOG Newsletter Archive
  • Active Downloads
  • Advanced Technology Radiation Therapy
  • Contouring Atlases
  • Anorectal
  • Bladder Atlas
  • Brachial Plexus Contouring Atlas
  • Breast Cancer Atlas
  • Female RTOG Normal Pelvis Atlas
  • GYN
  • H & N Atlases
  • Hippocampal Sparing
  • Male RTOG Normal Pelvis Atlas
  • Pancreas Atlas
  • Prostate Pelvic Lymph Nodes
  • Prostate Post-Op
  • RTOG Extremity Soft Tissue Sarcoma Atlas
  • Lung Atlas
  • Upper Abdominal Normal Organ Contouring Consensus
  • RADCOMP Breast Atlas
  • Vulvar Cancer Atlas
  • Standardized Naming Conventions
  • RTQA Protocol Prescription Guidelines
  • Approval Process
  • Education/Training
  • Advanced Imaging
  • Contact RTQA
  • TRIAD
 
Core Lab > Contouring Atlases > Lung Atlas

 

Minimize

RTOG 1106 OAR

RTOG 1106 Target Atlas

Copyright (c) 2019 RTOG  |  Privacy Statement |  Login
RTOG is a participant in National Cancer Institute research through NRG Oncology.